Cy7 NHS ester (A8109): Practical Labeling Guide

Cy7 NHS ester is a sulfonated, hydrophilic near-infrared fluorescent dye for labeling accessible amino groups on proteins, peptides, and related biomolecules. Its water compatibility is useful when an organic-solvent-heavy protocol could destabilize a sensitive protein. The product dossier reports excitation and emission maxima in the near-infrared range, making this reagent a practical near-infrared dye for bioimaging and a candidate protein labeling dye for in vitro or in vivo studies.

No directly matched paper evidence is available for this specific product and SKU. The guidance below therefore combines the product dossier with clearly identified workflow recommendations rather than claiming paper-validated reaction yields or biological outcomes. The Cy7 NHS ester product page should be checked for the current lot and handling information.

What This Product Solves

Many fluorescent conjugation workflows require a balance between sufficient dye loading and preservation of biomolecule function. Cy7 NHS ester addresses the solvent and optical side of that problem: it is designed to dissolve in water, DMF, and DMSO, while its sulfonate groups increase hydrophilicity. For delicate proteins, an aqueous-first workflow can reduce reliance on organic co-solvents. The same sulfonated design is described as reducing fluorescence quenching associated with dye-dye interactions, although the final signal still depends on labeling density, protein structure, and sample composition.

The reagent targets amino groups, so it is intended for biomolecule conjugation involving accessible primary amines rather than for arbitrary site-selective labeling. A purified conjugate can support near-infrared fluorescent imaging, tracking, or assay readouts. It may also serve as a fluorescent probe for live cell imaging, but cell exposure, uptake, toxicity, and background must be tested with the actual conjugate and assay conditions.

For a stepwise protein-labeling overview, see Cy7 NHS Ester: Protocols for Near-Infrared Protein Labeling; it complements this article by focusing on execution of amino-group labeling. For analytical controls and free-dye removal, see Cy7 NHS Ester: Practical Labeling and QC Guide; it is most relevant when designing conjugate characterization.

Protocol Parameters

The following entries separate dossier values from starting conditions that require optimization in the user’s system.

• Assay: near-infrared fluorescent imaging; Value: excitation maximum 750 nm; Applicability: instrument setup and excitation screening; Rationale: begin optical testing near the reported excitation maximum, then confirm performance in the complete sample matrix; product dossier.
• Assay: near-infrared fluorescent imaging; Value: emission maximum 773 nm; Applicability: emission-filter and detector selection; Rationale: collect signal around the reported emission maximum while checking for matrix-dependent background; product dossier.
• Assay: fluorescence quantification; Value: extinction coefficient 240,600 M⁻¹ cm⁻¹ and quantum yield 0.36; Applicability: concentration estimation and optical benchmarking; Rationale: these values provide a product-level reference, not a guarantee of brightness in every conjugate; product dossier.
• Assay: reagent preparation; Value: molecular mass 827.94 g mol⁻¹; Applicability: conversion of weighed material to molar quantity; Rationale: calculate moles from mass divided by molecular mass before setting the dye-to-biomolecule ratio; product dossier.
• Assay: conjugation reaction; Value: pH 7.5–8.5 as an initial screening range; Applicability: aqueous labeling of proteins or peptides; Rationale: use a mildly basic, amine-compatible condition and optimize for activity and labeling density; workflow recommendation, not a product specification.
• Assay: conjugation reaction; Value: 30–60 minutes as an initial incubation window; Applicability: small-scale optimization before production labeling; Rationale: compare reaction progress with protein recovery and function rather than treating this interval as universally validated; workflow recommendation, not a product specification.

Workflow Setup and QC Checklist

1. Prepare the biomolecule and buffer

Use a purified protein or peptide with known concentration and activity. Select a buffer that does not contain competing primary amines during the reaction. Tris, glycine, and ethanolamine are common examples to avoid during NHS-ester coupling; exchange the biomolecule into a compatible buffer if necessary. Record pH, protein concentration, buffer composition, and the number of available labeling sites that may be exposed.

2. Prepare Cy7 NHS ester immediately before use

Work under reduced light and minimize the time that the reagent remains in solution. Because the dossier describes water solubility, dissolve the material in water or the selected aqueous reaction buffer when the protein is solvent-sensitive. DMF or DMSO are listed as compatible solvents, but they should be introduced only when needed and at a level demonstrated to preserve the biomolecule. Do not plan long-term storage of the prepared solution; use it promptly.

3. Run a small labeling matrix

Instead of assuming one dye loading level, test a low, intermediate, and high dye-to-protein molar input on a small scale. Add the dye solution gradually with gentle mixing, and keep a matched unlabeled protein control. The optimum is the condition that provides an acceptable fluorescence signal while retaining solubility, recovery, and biological activity. Labeling density should be determined experimentally for each protein.

4. Remove unreacted dye

Separate free Cy7 NHS ester and hydrolyzed dye from the conjugate using a method appropriate for molecular size, such as desalting, size-exclusion chromatography, dialysis, or centrifugal ultrafiltration. Confirm that the cleanup method does not cause excessive sample loss. A free-dye control processed in parallel can help identify background contributed by incomplete separation.

5. Confirm the conjugate before imaging

Measure absorbance or fluorescence using instrument settings appropriate for the reported 750 nm excitation and 773 nm emission maxima. If absorbance at 750 nm is used for a first-pass dye estimate, the dossier extinction coefficient can support the calculation c = A750 / (240600 × l), where l is the optical path length in centimeters. Keep measurements within the validated linear range of the instrument and account for scattering or sample background.

Use at least one orthogonal check, such as protein concentration measurement, gel-based fluorescence, or chromatographic separation. Compare labeled and unlabeled material for aggregation, recovery, mobility, and retained assay activity. For live cell imaging or animal studies, also test the cleaned conjugate for biological compatibility and establish an imaging background control before interpreting distribution data.

Common Failure Modes and Fixes

• Low or inconsistent labeling: competing amines, unsuitable pH, inaccessible amino groups, hydrolyzed reagent, or inaccurate concentration calculations can reduce coupling. Use an amine-free reaction buffer, prepare the reagent immediately before use, verify biomolecule concentration, and repeat a small loading matrix.
• Protein precipitation or activity loss: excessive dye input, local concentration spikes, prolonged exposure to DMF or DMSO, or incompatible buffer conditions may destabilize the sample. Add reagent gradually, reduce the dye input, favor an aqueous formulation, and compare activity with an unlabeled control.
• Weak imaging signal: the detector may not be configured near the product’s optical maxima, or the conjugate may contain too little dye. Check excitation and emission settings, remove free dye, verify conjugate concentration, and assess whether high labeling density is causing unfavorable dye-dye interactions.
• High background: residual free dye, incomplete purification, sample autofluorescence, or nonspecific binding can obscure the conjugate. Include free-dye and unlabeled controls, extend or change the cleanup method, and measure background in the exact imaging matrix.
• Run-to-run drift: light exposure, aged solutions, repeated freeze-thaw handling, and variable protein quality can change results. Store the solid reagent at −20 °C in the dark, use small aliquots, and record preparation and purification details for every batch.

Scope and Limitations

Cy7 NHS ester is an amino-group labeling reagent, not a universal conjugation reagent. It does not establish a defined labeling site, and modification of accessible lysines or terminal amines can alter charge, activity, binding, or biodistribution. A water-soluble formulation also does not ensure compatibility with every buffer, cell type, or biological matrix.

The dossier specifies storage at −20 °C in the dark for up to 24 months after receipt and transport at room temperature for up to 3 weeks. These conditions should not be interpreted as a validated long-term stability claim for opened material, prepared solutions, or final conjugates. Avoid prolonged light exposure, and determine final-conjugate stability experimentally. The reported optical values are useful benchmarks, but pH, aggregation, protein environment, instrument configuration, and free-dye contamination can shift observed performance. No paper-derived yield, imaging depth, toxicity result, or in vivo efficacy should be inferred without independent validation.

Conclusion

Cy7 NHS ester provides a practical aqueous-compatible route for preparing near-infrared fluorescent protein and peptide conjugates. The most reliable workflow is to use an amine-compatible buffer, prepare the reagent immediately before labeling, screen dye loading on a small scale, remove free dye thoroughly, and verify both optical quality and biomolecule function. Treat the dossier values as product benchmarks and the recommended reaction conditions as starting points for optimization.